Companies / Mesa Laboratories Inc /Co/
Mesa Laboratories Inc /Co/
Nasdaq: MLABCIK 724004LAKEWOOD, CO
Financials · FY2026
Ownership
5.6M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.66% | 37,135 |
| Institutions | 87.88% | 4,917,678 |
| Public float | 11.46% | 641,056 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Sakys JohnCFO | 0.35% | 19,785 |
Ladiwala Shiraz ShabanaliDirector | 0.15% | 8,523 |
Tripeny R TonyDirector | 0.10% | 5,398 |
Capone Mark ChristopherDirector | 0.06% | 3,429 |
Institutional holders 160
View all →| Holder | Value | % of shares |
|---|---|---|
| $43.86M | 7.87% | |
| $25.27M | 5.75% | |
| $23.76M | 4.80% | |
| $17.94M | 3.63% | |
| $17.84M | 4.06% | |
| $16.21M | 3.69% | |
| $15.08M | 3.05% | |
| $14.03M | 3.19% | |
| $13.78M | 3.14% | |
| $13.73M | 2.78% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Sakys John Executive | Exercise | Common Stock | $282.8K | +3K +18.06% | 17,761 0.32% of shares | low |
| Jun 18, 2026 | Sakys John Executive | Exercise | Common Stock | $262.1K | +3K +15.68% | 20,330 0.36% of shares | low |
| Jun 22, 2026 | Sakys John Executive | Sell | Common Stock | $253.0K | -3K -12.50% | 19,785 0.35% of shares | medium |
| Mar 10, 2026 | Ladiwala Shiraz Shabanali Director | Buy | Common Stock | $252.8K | +4K +69.68% | 8,523 0.15% of shares | medium |
| Jun 18, 2026 | Sakys John Executive | Grant | Common Stock | $217.0K | +2K +11.22% | 22,612 0.40% of shares | low |
| Jun 16, 2026 | Sakys John Executive | Sell | Common Stock | $123.8K | -1K -6.89% | 16,538 0.30% of shares | medium |
| Mar 10, 2026 | Tripeny R Tony Director | Buy | Common Stock | $99.9K | +1K +32.21% | 5,398 0.10% of shares | medium |
| Mar 10, 2026 | Capone Mark Christopher Director | Buy | Common Stock | $99.3K | +1K +61.14% | 3,429 0.06% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Long Path Smaller Companies Fund, LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MLAB | — | 59064R109 |